Laboratories Receive Extended Drug License Deadlines
The National Agency for Medicines and Health Products announces an exceptional extension of the deadlines for submitting the electronic joint technical files for drug permits, aimed at facilitating the transition to the standardized international format. The deadline for re-submitting applications for drug distribution licenses submitted in 2025 has been extended to December 31, 2026, while new applications submitted in 2026 are extended to March 31, 2027. Additionally, the agency temporarily allows the continued submission of renewal applications using the current format until the end of 2026. Starting from January 1, 2027, submission of files must be made in the unified electronic format, with guidelines and techniques provided to minimize errors and ensure compliance.
Notice: This Is an AI-Generated Summary
Comments (0)